|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 10 June 2008
doi: 10.1242/jcs.021717
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
confers alterations in cell-surface presentation of TGF
and cytoskeletal organizationDepartment of Cell and Tissue Biology, Program in Cell Biology, University of California–San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
* Author for correspondence (e-mail: rik.derynck{at}ucsf.edu)
Accepted 9 April 2008
Ligand presentation is a major determinant of receptor activation. The epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, is activated by growth factors of the transforming growth factor
(TGF
) family. The tetraspanin CD9 interacts with transmembrane TGF
and decreases its ectodomain shedding to release soluble TGF
. Here we report that CD9 has a role in the maturation of transmembrane TGF
and its stabilization at the cell surface, and in the cell-surface distribution in polarized epithelial cells. Furthermore, coexpression of CD9 and TGF
confers changes in cytoskeletal organization with a decrease in actin stress fibers and focal adhesions, and changes in RhoA and Rac1 GTPase activity. These alterations are reversed by blocking EGFR signaling. Finally, we demonstrate changes in cell adhesion and migration resulting from coexpression of TGF
with CD9. These results provide insight into the role of CD9 in the presentation of TGF
in epithelial and carcinoma cells, whose physiology is driven by ligand-induced EGFR activation.
Key words: Epithelial cells, Tetraspanin, Transforming growth factor 
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?